BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7430356)

  • 1. Monocytes in inflammatory bowel disease: absolute monocyte counts.
    Mee AS; Berney J; Jewell DP
    J Clin Pathol; 1980 Oct; 33(10):917-20. PubMed ID: 7430356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
    Mazlam MZ; Hodgson HJ
    Gut; 1994 Jan; 35(1):77-83. PubMed ID: 8307455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Falchuk KR; Perrotto JL; Isselbacher KJ
    N Engl J Med; 1975 Feb; 292(8):395-7. PubMed ID: 1110725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
    Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
    Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.
    Rhodes JM; Jewell DP
    Gut; 1983 Jan; 24(1):73-7. PubMed ID: 6848434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity.
    Mee AS; Jewell DP
    Clin Sci (Lond); 1980 Apr; 58(4):295-300. PubMed ID: 7379454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood T and B cells in chronic inflammatory bowel disease.
    Strickland RG; Korsmeyer S; Soltis RD; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):569-77. PubMed ID: 4547268
    [No Abstract]   [Full Text] [Related]  

  • 13. The nitroblue tetrazolium test in Crohn's disease and ulcerative colitis.
    Ward M; Eastwood MA
    Digestion; 1976; 14(2):179-83. PubMed ID: 950081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
    Mazlam MZ; Hodgson HJ
    Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients.
    Zelante A; Borgoni R; Galuppi C; Cifalà V; Melchiorri L; Gullini S; Baricordi O; Rizzo R
    Inflamm Bowel Dis; 2011 Aug; 17(8):E94-5. PubMed ID: 21604331
    [No Abstract]   [Full Text] [Related]  

  • 16. Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing.
    Mee AS; Szawatakowski M; Jewell DP
    J Clin Pathol; 1980 Oct; 33(10):921-5. PubMed ID: 7430357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
    Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
    World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
    Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.